D J Moss

STERILE IMMUNITY - GENERAL DISCUSSION-I

Ian H. Frazer, Fy Liew, D J Moss, 1994 .

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus

D J Moss, E. Kieff, S. L. Silins, 1994, The Journal of experimental medicine.

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.

D J Moss, R Khanna, S. Burrows, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro.

J. H. Pope, D J Moss, D. Moss, 1972, The Journal of general virology.

Cost-efficient quantification of enzyme-linked immunospot.

D J Moss, P G Parsons, M Bharadwaj, 2001, BioTechniques.

Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies

D J Moss, R Khanna, S. L. Silins, 1996, Journal of virology.

Human malignant melanoma cell lines.

J. H. Pope, D J Moss, L. Morrison, 1979, Pathology.